These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 28738057

  • 1. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    Huh JH, Kim JY, Choi E, Kim JS, Chang Y, Sung KC.
    PLoS One; 2017; 12(7):e0180951. PubMed ID: 28738057
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH, Kang D, Jang HR, Gu S, Cho SJ, Paik SW, Ryu S, Chang Y, Lazo M, Guallar E, Cho J, Gwak GY.
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M, Zhao Z, Qin G, Chen L, Lu J, Huo Y, Chen L, Zeng T, Xu M, Chen Y, Wang T, Wang S, Xu Y, Shi L, Tang X, Su Q, Yu X, Yan L, Wan Q, Chen G, Gao Z, Wang G, Shen F, Luo Z, Zhang Y, Liu C, Wang Y, Hu R, Ye Z, Wu S, Deng H, Yang T, Li Q, Qin Y, Mu Y, Zhao J, Ning G, Bi Y, Xu Y, Wang W.
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [Abstract] [Full Text] [Related]

  • 9. Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study.
    Chung GE, Han K, Lee KN, Bae JH, Yang SY, Choi SY, Yim JY, Heo NJ.
    Diabetes Metab; 2023 Jul; 49(4):101454. PubMed ID: 37244418
    [Abstract] [Full Text] [Related]

  • 10. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.
    Miyakoshi T, Nakasone Y, Sato Y, Yamauchi K, Hashikura R, Takayama M, Hirabayashi K, Koike H, Moriya T, Aizawa T.
    Nephrology (Carlton); 2017 Sep; 22(9):684-689. PubMed ID: 27282755
    [Abstract] [Full Text] [Related]

  • 11. The Fatty Liver Index's Association with Incident Chronic Kidney Disease in Korean Middle-Aged Adults: A Community-Based Cohort Study.
    Lee HH, Ro H, Jung JY, Chang JH, Chung W, Kim AJ.
    J Clin Med; 2024 Mar 12; 13(6):. PubMed ID: 38541842
    [Abstract] [Full Text] [Related]

  • 12. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R, Ritchie J, Green D, Kalra PA.
    Nephrol Dial Transplant; 2019 Mar 01; 34(3):449-457. PubMed ID: 29390103
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K, Thongprayoon C, Scribani M, Ungprasert P, Cheungpasitporn W.
    Eur J Gastroenterol Hepatol; 2018 Apr 01; 30(4):404-410. PubMed ID: 29215435
    [Abstract] [Full Text] [Related]

  • 14. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
    Tanaka M, Mori K, Takahashi S, Higashiura Y, Ohnishi H, Hanawa N, Furuhashi M.
    Nephrol Dial Transplant; 2023 Feb 28; 38(3):700-711. PubMed ID: 35612975
    [Abstract] [Full Text] [Related]

  • 15. High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Xu HW, Hsu YC, Chang CH, Wei KL, Lin CL.
    Hepatol Int; 2016 Mar 28; 10(2):340-6. PubMed ID: 26676626
    [Abstract] [Full Text] [Related]

  • 16. Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects.
    Takahashi S, Tanaka M, Furuhashi M, Moniwa N, Koyama M, Higashiura Y, Osanami A, Gocho Y, Ohnishi H, Numata K, Hisasue T, Hanawa N, Miura T.
    Sci Rep; 2021 Apr 21; 11(1):8606. PubMed ID: 33883636
    [Abstract] [Full Text] [Related]

  • 17. Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.
    Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza GL, Valenti L, Byrne CD, Maffeis C, Bonora E, Targher G.
    Diabetes Metab; 2019 Oct 21; 45(5):480-487. PubMed ID: 30763699
    [Abstract] [Full Text] [Related]

  • 18. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
    Önnerhag K, Dreja K, Nilsson PM, Lindgren S.
    Clin Res Hepatol Gastroenterol; 2019 Oct 21; 43(5):542-550. PubMed ID: 30827925
    [Abstract] [Full Text] [Related]

  • 19. Association between the fatty liver index and chronic kidney disease: the population-based KORA study.
    Cai X, Thorand B, Hohenester S, Koenig W, Rathmann W, Peters A, Nano J.
    Nephrol Dial Transplant; 2023 May 04; 38(5):1240-1248. PubMed ID: 36150717
    [Abstract] [Full Text] [Related]

  • 20. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H, Dawwas GK, Liu X, Nguyen MH.
    J Intern Med; 2019 Dec 04; 286(6):711-722. PubMed ID: 31359543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.